BioViva Overview
- Year Founded
-
2014

- Status
-
Private
- Employees
-
12

- Latest Deal Type
-
Seed
- Latest Deal Amount
-
$400K
BioViva General Information
Description
Operator of a biotech company intended to offer precision-based medicines as per requirements and human needs. The company's platform leverages adeno-associated virus (AAV) and cytomegalovirus (CMV) for gene delivery of larger genetic payloads, enabling the development of gene therapies to treat aging and age-related diseases.
Contact Information
Website
www.bioviva-science.comCorporate Office
- 6580 North East Honeysuckle Lane
- Bainbridge Island, WA 98110
- United States
Corporate Office
- 6580 North East Honeysuckle Lane
- Bainbridge Island, WA 98110
- United States
BioViva Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
3. Seed Round | 25-Dec-2022 | $400K | Completed | Generating Revenue | ||
2. Equity Crowdfunding | Completed | Startup | ||||
1. Angel (individual) | 27-May-2015 | $250K | $250K | Completed | Startup |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
BioViva Comparisons
Industry
Financing
Details
BioViva Competitors (67)
One of BioViva’s 67 competitors is Century Therapeutics, a Formerly VC-backed company based in Philadelphia, PA.
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Century Therapeutics | Formerly VC-backed | Philadelphia, PA | ||||
Providence Therapeutics | Venture Capital-Backed | Calgary, Canada | ||||
Hookipa Pharma | Formerly VC-backed | New York, NY | ||||
Gradalis | Private Equity-Backed | Carrollton, TX | ||||
Kite Pharma | Formerly VC-backed | Santa Monica, CA |
BioViva Patents
BioViva Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-20220401583-A1 | Treatment of age-related cognitive decline using genetically modified viral vectors | Pending | 16-Jun-2021 | ||
EP-4355374-A1 | Treatment of age-related cognitive decline using genetically modified viral vectors | Pending | 16-Jun-2021 | ||
US-20220251603-A1 | Systems and methods for gene therapy via administration of genetically modified viral vectors | Pending | 05-Feb-2021 | ||
EP-4288554-A1 | Systems and methods for gene therapy via administration of genetically modified viral vectors | Pending | 05-Feb-2021 | ||
US-20220177921-A1 | Gene therapy using genetically modified viral vectors | Pending | 27-Aug-2018 | A61K48/005 |
BioViva Signals
BioViva FAQs
-
When was BioViva founded?
BioViva was founded in 2014.
-
Where is BioViva headquartered?
BioViva is headquartered in Bainbridge Island, WA.
-
What is the size of BioViva?
BioViva has 12 total employees.
-
What industry is BioViva in?
BioViva’s primary industry is Biotechnology.
-
Is BioViva a private or public company?
BioViva is a Private company.
-
What is BioViva’s current revenue?
The current revenue for BioViva is
. -
How much funding has BioViva raised over time?
BioViva has raised $4.65M.
-
Who are BioViva’s competitors?
Century Therapeutics, Providence Therapeutics, Hookipa Pharma, Gradalis, and Kite Pharma are some of the 67 competitors of BioViva.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »